Are you ready to transform your patent practice?
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
(gradient)+(2).png?width=2188&name=Juristat_Primary+(white+text)(gradient)+(2).png "Juristat | Patent analytics & workflow automation")
(gradient).png?width=2188&name=Juristat_Primary+(grey+text)(gradient).png "Juristat | Patent analytics & workflow automation")
James Cosgrove
The USPTO: A Snapshot
An Overview of Patent Prosecution Trends at the USPTO Since the Year 2000
Since the year 2000,.
Juristat 2017 Year in Review
Over the past year, we have published articles covering a wide range of topics, from handling .
How the Choice of a Rejection Response Can Impact Your Prosecution Timeline
One of the biggest questions every client wants to know is “how long will patent prosecution take?”.
The Most Difficult Examiners at the USPTO (2017)
In July of 2016, we published an article titled “The Most Difficult Examiners at the USPTO,” in.
The Top Firms for Chemistry and Chemical Engineering
ELIGIBILITY & METHODOLOGY
Much like the Juristat Top 100, this list is unique in that it considers.
The Art Units with the Highest and Lowest Alice Allowance Rates
In the three-plus years since Alice was decided, we’ve seen the case take quite a toll on the.
The Best Art Units for AFCP 2.0 Requests
The AFCP 2.0 program was established in 2012 to provide applicants with an alternative to RCEs. The.
Evaluating the Lasting Impact of Mayo/Myriad
As precursors to the more wide-ranging Alice decision and the USPTO guidance that came after it,.
The Top Firms for Handling Mayo/Myriad Rejections
Ever since Mayo was decided in 2012, the percentage of § 101 rejections on biotech, pharma, and.